European drug watchdog reviews AstraZeneca anti-covid cocktail Evusheld

The move comes after AstraZeneca this week said trials showed that the drug, made from a combination of two monoclonal antibodies, reduced severe COVID-19 symptoms and deaths.

Read the full story: Read More